In our new report: Why glycomics, the study of sugars on cells, is at the centre of a new surge of scientific and industry interest.
Category: Community
Top 10 stories from GlycoNet in 2021
A year in review in glycomics innovations.
Announcing the new GlycoNet Trainee Association Executive Committee
The committee will support GlycoNet trainees in advancing their skills and knowledge through professional development activities.
GlycoNet Mini-Symposium gathered trainees from coast to coast
The event brought together trainees from Western, Central, and East Coast regions to network and exchange knowledge.
GlycoNet receives government funding to encourage confidence in vaccines across the country
The grant will help deliver reliable vaccine information to help Canadians make evidence-based decisions on vaccines.
GlycoNet start-up listed as top 10 therapeutics start-ups and companies in Edmonton
48Hour Discovery shows exceptional innovation, growth, management, and societal impact, according to BestStartup.
GlycoNet Investigator meets the Parliamentary Health Research Caucus to present glycomics research
Dr. Yves St-Pierre shared how glycomics could help develop a new-generation cancer immunotherapy.
GlycoNet Investigator featured in “100 Lives of Insulin” project
Dr. Mike Riddell has spent his career looking at ways to make diabetes easier and safer for those who are living with it. He talks about the why and how behind it.
Canadian company blazes a new trail to drug development
A prime example of Canada’s success in the sub‑sector of the life sciences industry is 48Hour Discovery
GlycoNet joins BioTalent Canada’s partnership network
Partnership will improve the career prospects in the biotechnology and life sciences sectors in Canada
English 
French